Lineage Cell Therapeutics (LCTX) Goodwill (2019 - 2026)

Lineage Cell Therapeutics' Goodwill history runs 8 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• In Q1 2026, Goodwill changed 0.0% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (changed 0.0% YoY), while the FY2025 annual figure was $10.7 million, changed 0.0% from the prior year.
• Goodwill for Q1 2026 stood at $10.7 million, roughly flat from $10.7 million in the prior quarter.
• The five-year high for Goodwill was $10.7 million in Q1 2022, with the low at $10.7 million in Q1 2022.
• The 5-year median for Goodwill is $10.7 million (2022), against an average of $10.7 million.
• Peak annual rise in Goodwill reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Lineage Cell Therapeutics' Goodwill stood at $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then changed by 0.0% to $10.7 million in 2024, then changed by 0.0% to $10.7 million in 2025, then changed by 0.0% to $10.7 million in 2026.
• Business Quant data shows LCTX's Goodwill at $10.7 million in Q1 2026, $10.7 million in Q4 2025, and $10.7 million in Q3 2025.